SCHEMBL6959823

SCHEMBL6959823

CCC(O)c1cn(C(c2ccccc2)(c2ccccc2)c2ccccc2)c(-c2cscc2C)n1

nearest known ligand 0.35

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 2/20 0.35
CYP2B6 P20813 2/20 0.35
CYP17A1 P05093 2/20 0.33
GRM2 Q14416 1/20 0.33
CYP2E1 P05181 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
LMNA P02545 1/20 0.31
RECQL P46063 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6970351 0.87 CYP2A6 (0.38) CYP2A6CYP2B6GRM2CYP2E1CYP3A4
SCHEMBL6963771 0.79
SCHEMBL5060964 0.65 LMNA (0.40) LMNARECQL
SCHEMBL31359403 0.64 MEN1 (0.31) CYP2D6
SCHEMBL7809080 0.62 MAPT (0.34)
SCHEMBL3502446 0.62 SMN1; SMN2 (0.30)
SCHEMBL5692289 0.62 KDM4E (0.41) CYP2D6LMNA
SCHEMBL6963184 0.61 CYP11B1 (0.33)
SCHEMBL23704620 0.60 HSP90AA1 (0.32)
SCHEMBL10982355 0.59 ALDH1A1 (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0954521-B1 4- (THIEN-3-YL)METHYL] IMIDAZOLE DERIVATIVES HAVING ALPHA2-ADRENOCEPTOR AGONISTIC ACTIVITY ORTHO MCNEIL PHARM INC (US) 2003-05-14 EP disclosed
EP-0954521-A1 4- (THIEN-3-YL)METHYL] IMIDAZOLE DERIVATIVES HAVING ALPHA2-ADRENOCEPTOR AGONISTIC ACTIVITY Ortho-McNeil Pharmaceutical, Inc. (US) 1999-11-10 EP disclosed
WO-1997035858-A1 4-[(THIEN-3-YL)METHYL] IMIDAZOLE DERIVATIVES HAVING α2-ADRENOCEPTOR AGONISTIC ACTIVITY ORTHO PHARMACEUTICAL CORPORATION (US) 1997-10-02 WO disclosed